Is a
Patent attributes
Patent Applicant
Patent Jurisdiction
Patent Number
Date of Patent
October 30, 2018
Patent Application Number
15134223
Date Filed
April 20, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure provides pyrrolopyrimidine compounds and methods of use therefor. For example, the disclosure provides certain pyrrolopyrimidine compounds capable of inhibiting JAK kinases. The disclosure further provides the pharmaceutical compositions containing these pyrrolopyrimidine compounds, and use of these pyrrolopyrimidine compounds in the treatment of disorders or diseases, such as inflammatory diseases and cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.